Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Virginia L. Stauffer |
Documentos disponibles escritos por este autor (5)
Refinar búsquedaIs the Noradrenergic Symptom Cluster a Valid Construct in Adjunctive Treatment of Major Depressive Disorder? / Virginia L. Stauffer en The Journal of Clinical Psychiatry, Año 2017 - Vol.78 - No.3 ([24/10/2017])
Título : Is the Noradrenergic Symptom Cluster a Valid Construct in Adjunctive Treatment of Major Depressive Disorder? Tipo de documento: texto impreso Autores: Virginia L. Stauffer, Autor ; Peng Liu, Autor ; Celine Goldberger, Autor Fecha de publicación: 2017 Artículo en la página: pp.317-323 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Monoterapia. Resumen: To identify symptoms potentially representative of a noradrenergic symptom cluster as possible predictors of response to the selective norepinephrine reuptake inhibitor (NRI) edivoxetine when used as monotherapy or adjunctive treatment in patients with DSM-IV-TR major depressive disorder (MDD). Link: ./index.php?lvl=notice_display&id=9662
in The Journal of Clinical Psychiatry > Año 2017 - Vol.78 - No.3 [24/10/2017] . - pp.317-323[artículo] Is the Noradrenergic Symptom Cluster a Valid Construct in Adjunctive Treatment of Major Depressive Disorder? [texto impreso] / Virginia L. Stauffer, Autor ; Peng Liu, Autor ; Celine Goldberger, Autor . - 2017 . - pp.317-323.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2017 - Vol.78 - No.3 [24/10/2017] . - pp.317-323
Palabras clave: Trastorno depresivo mayor, Monoterapia. Resumen: To identify symptoms potentially representative of a noradrenergic symptom cluster as possible predictors of response to the selective norepinephrine reuptake inhibitor (NRI) edivoxetine when used as monotherapy or adjunctive treatment in patients with DSM-IV-TR major depressive disorder (MDD). Link: ./index.php?lvl=notice_display&id=9662
Título : Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia : An analysis of correlations with efficacy, weight gain, and prolactin concentration Tipo de documento: texto impreso Autores: Leslie L. Citrome, Autor ; Virginia L. Stauffer, Autor ; Lei Chen, Autor Fecha de publicación: 2022 Artículo en la página: pp. 278-283 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Olanzapina, Farmacocinética, Prolactina, Esquizofrenia, Tabaquismo. Resumen: Objectives of the study were to evaluate the relationship between olanzapine plasma concentrations and efficacy, prolactin, and weight and to assess effects of smoking, sex, and race on the pharmacokinetic characteristics of oral olanzapine up to 40 mg/d. Patients were randomly allocated to olanzapine 10, 20, or 40 mg/d for 8 weeks. Olanzapine concentrations in 634 samples from 380 patients were analyzed. Link: ./index.php?lvl=notice_display&id=29510
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 3 (Junio) . - pp. 278-283[artículo] Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia : An analysis of correlations with efficacy, weight gain, and prolactin concentration [texto impreso] / Leslie L. Citrome, Autor ; Virginia L. Stauffer, Autor ; Lei Chen, Autor . - 2022 . - pp. 278-283.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 3 (Junio) . - pp. 278-283
Palabras clave: Olanzapina, Farmacocinética, Prolactina, Esquizofrenia, Tabaquismo. Resumen: Objectives of the study were to evaluate the relationship between olanzapine plasma concentrations and efficacy, prolactin, and weight and to assess effects of smoking, sex, and race on the pharmacokinetic characteristics of oral olanzapine up to 40 mg/d. Patients were randomly allocated to olanzapine 10, 20, or 40 mg/d for 8 weeks. Olanzapine concentrations in 634 samples from 380 patients were analyzed. Link: ./index.php?lvl=notice_display&id=29510
Título : Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia Tipo de documento: texto impreso Autores: Bruce J. Kinon, Autor ; Virginia L. Stauffer, Autor Fecha de publicación: 2023 Artículo en la página: pp. 601-607 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Enfermedad aguda, Agentes antipsicóticos, Benzodiazepinas, Glucosa en sangre/efectos por medicamentos, Hospitalización, Lorazepam, Olanzapina, Piperazinas, Agitación psicomotora, Agitación psicomotora, Esquizofrenia. Resumen: Rapid control of agitation is of critical importance in the treatment of acutely ill patients with schizophrenia. Both olanzapine and aripiprazole have been shown to be safe and effective in this setting, with each having somewhat different receptor binding affinity profiles. Link: ./index.php?lvl=notice_display&id=30817
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 601-607[artículo] Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia [texto impreso] / Bruce J. Kinon, Autor ; Virginia L. Stauffer, Autor . - 2023 . - pp. 601-607.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 601-607
Palabras clave: Enfermedad aguda, Agentes antipsicóticos, Benzodiazepinas, Glucosa en sangre/efectos por medicamentos, Hospitalización, Lorazepam, Olanzapina, Piperazinas, Agitación psicomotora, Agitación psicomotora, Esquizofrenia. Resumen: Rapid control of agitation is of critical importance in the treatment of acutely ill patients with schizophrenia. Both olanzapine and aripiprazole have been shown to be safe and effective in this setting, with each having somewhat different receptor binding affinity profiles. Link: ./index.php?lvl=notice_display&id=30817
Título : Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder : post hoc analyses of 3 randomized, controlled clinical trials Tipo de documento: texto impreso Autores: Vicki P Hoffmann, Autor ; Michael Case, Autor ; Virginia L. Stauffer, Autor Fecha de publicación: 2022 Artículo en la página: pp. 656-660 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Glucosa, Peso, Triglicéridos, Antipsicóticos Resumen: The objective of this study was to determine if early changes in triglycerides and weight may be useful in predicting longer-term changes in weight and other metabolic parameters. Data were from three 24- to 28-week randomized, controlled studies comparing olanzapine to ziprasidone or aripiprazole for treatment of schizophrenia. Link: ./index.php?lvl=notice_display&id=29411
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 656-660[artículo] Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder : post hoc analyses of 3 randomized, controlled clinical trials [texto impreso] / Vicki P Hoffmann, Autor ; Michael Case, Autor ; Virginia L. Stauffer, Autor . - 2022 . - pp. 656-660.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 656-660
Palabras clave: Glucosa, Peso, Triglicéridos, Antipsicóticos Resumen: The objective of this study was to determine if early changes in triglycerides and weight may be useful in predicting longer-term changes in weight and other metabolic parameters. Data were from three 24- to 28-week randomized, controlled studies comparing olanzapine to ziprasidone or aripiprazole for treatment of schizophrenia. Link: ./index.php?lvl=notice_display&id=29411
Título : Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder : A randomized, double-blind, fixed-dose study Tipo de documento: texto impreso Autores: Bruce J. Kinon, Autor ; Jan Volavka, Autor ; Virginia L. Stauffer, Autor Fecha de publicación: 2023 Artículo en la página: pp. 392-400 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Relación Dosis-Respuesta, Olanzapina, Prolactina, Trastornos psicóticos, Esquizofrenia. Resumen: The objective of this study was to assess the dose-response relationship of standard and higher doses of olanzapine in a randomized, double-blind, 8-week, fixed-dose study comparing olanzapine 10 (n = 199), 20 (n = 200), and 40 mg/d (n = 200) for patients with schizophrenia or schizoaffective disorder and suboptimal response to current treatment. Patients meeting criteria for antipsychotic treatment resistance were excluded. Link: ./index.php?lvl=notice_display&id=30838
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 4 (Agosto) . - pp. 392-400[artículo] Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder : A randomized, double-blind, fixed-dose study [texto impreso] / Bruce J. Kinon, Autor ; Jan Volavka, Autor ; Virginia L. Stauffer, Autor . - 2023 . - pp. 392-400.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 4 (Agosto) . - pp. 392-400
Palabras clave: Antipsicóticos, Benzodiazepinas, Relación Dosis-Respuesta, Olanzapina, Prolactina, Trastornos psicóticos, Esquizofrenia. Resumen: The objective of this study was to assess the dose-response relationship of standard and higher doses of olanzapine in a randomized, double-blind, 8-week, fixed-dose study comparing olanzapine 10 (n = 199), 20 (n = 200), and 40 mg/d (n = 200) for patients with schizophrenia or schizoaffective disorder and suboptimal response to current treatment. Patients meeting criteria for antipsychotic treatment resistance were excluded. Link: ./index.php?lvl=notice_display&id=30838
